Kevin Lou

10PUBLICATIONS
140CO-AUTHORS
Predictive and prognostic markersMolecular targetsGlycoconjugatesBiologically active moleculesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 15, 2026
Single-cell transcriptomic unveils tumor-mediated reprogramming of neutrophils and their unique vulnerability that inhibits metastasis.

|Feb 24, 2026
The GENEVA platform models tumor mosaicism to reveal variations of responses to KRAS inhibitors and identify improved drug combinations.

Johnny X Yu, Jung Min Suh, Katerina D Popova

|Aug 12, 2025
Programmable translational inhibition by a molecular glue-oligonucleotide conjugate.

Siyi Wang, Joanna R Kovalski, Francisco J Zapatero-Belinchón

|Dec 08, 2022
IFITM proteins assist cellular uptake of diverse linked chemotypes.

Kevin Lou, Douglas R Wassarman, Tangpo Yang

|Sep 14, 2022
Brain-restricted mTOR inhibition with binary pharmacology.

Ziyang Zhang, Qiwen Fan, Xujun Luo

|Jun 09, 2020
A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing.

David E Gordon, Gwendolyn M Jang, Mehdi Bouhaddou

Pageof 2

Frequent Collaborators

10 joint publications

Kevan Shokat

4 joint publications

Ziyang Zhang

4 joint publications

Danielle L Swaney

3 joint publications

Nevan J Krogan